1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Carcinoma, Anaplastic

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Carcinoma, Anaplastic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Areces, L; Bussolati, G; Cassoni, P; Chini, B; Chinol, M; Manning, M; Marrocco, T; Paganelli, G; Papi, S; Reversi, A	1
Axworthy, DB; Beaumier, PL; Fritzberg, AR; Gustavson, LM; Hobson, LJ; Hylarides, MD; Mallett, RW; Reno, JM; Su, F; Theodore, LJ	1

Other Studies

2 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Carcinoma, Anaplastic

Article	Year
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue. British journal of cancer, 2003, Sep-01, Volume: 89, Issue:5 Topics: Animals; Breast Neoplasms; Carcinoma; Chelating Agents; COS Cells; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Mice; Neoplasms; Oxytocin; Protein Binding; Radioactive Tracers; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Oxytocin; Sensitivity and Specificity; Stomach Neoplasms; Tissue Distribution; Transfection; Tumor Cells, Cultured; Vasotocin	2003
Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proceedings of the National Academy of Sciences of the United States of America, 2000, Feb-15, Volume: 97, Issue:4 Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Cell Adhesion Molecules; Chelating Agents; Colonic Neoplasms; Epithelial Cell Adhesion Molecule; Heterocyclic Compounds, 1-Ring; Humans; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Radioimmunotherapy; Radiopharmaceuticals; Transplantation, Heterologous; Yttrium Radioisotopes	2000

Article

Year

Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue.

British journal of cancer, 2003, Sep-01, Volume: 89, Issue:5

Topics: Animals; Breast Neoplasms; Carcinoma; Chelating Agents; COS Cells; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Mice; Neoplasms; Oxytocin; Protein Binding; Radioactive Tracers; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Oxytocin; Sensitivity and Specificity; Stomach Neoplasms; Tissue Distribution; Transfection; Tumor Cells, Cultured; Vasotocin

2003

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity.

Proceedings of the National Academy of Sciences of the United States of America, 2000, Feb-15, Volume: 97, Issue:4

Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Cell Adhesion Molecules; Chelating Agents; Colonic Neoplasms; Epithelial Cell Adhesion Molecule; Heterocyclic Compounds, 1-Ring; Humans; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Radioimmunotherapy; Radiopharmaceuticals; Transplantation, Heterologous; Yttrium Radioisotopes

2000